Given the role of inflammatory activation by TLR4 in atherogenesis [24], our finding of LBP in human coronary artery plaques in vivo, and plaque-derived systemic release of LBP are novel findings that justify further consideration of LBP as a pathogenic factor in coronary artery disease. The gene discussed is LBP; the disease is coronary artery disorder.